US 10913948
RNA interference in dermal and fibrotic indications
granted A61PA61P1/00A61P1/16
Quick answer
US patent 10913948 (RNA interference in dermal and fibrotic indications) held by Phio Pharmaceuticals Corp. expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Phio Pharmaceuticals Corp.
- Grant date
- Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P11/00, A61P13/00